EMERGING APPROACHES TO COMBINATION THERAPIES IN AMD & DME - Aerpio Therapeutics
Combination Therapies
description
Transcript of Combination Therapies
![Page 1: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/1.jpg)
Combination Therapies: the promise to cure… everything??
By I&C President Ryan WittBy I&C President Ryan Witt
[email protected]@gmail.com
![Page 2: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/2.jpg)
Cure everything???!?Cure everything???!?
CancerCancer Cardiovascular Cardiovascular
diseasedisease Alzheimer’s DiseaseAlzheimer’s Disease Bacterial InfectionsBacterial Infections
Yes. I’ll Explain.Yes. I’ll Explain.
ALSALS Multiple SclerosisMultiple Sclerosis HIV/AIDSHIV/AIDS HepatitisHepatitis
![Page 3: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/3.jpg)
But, RememberBut, Remember
Ask Ask QQs!s!
AlwaysAlways ask “How, Why, What, and ask “How, Why, What, and When”When”
Try to Understand EVERYTHING!Try to Understand EVERYTHING!
![Page 4: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/4.jpg)
ConceptConcept
With a With a knowledgeknowledge-based approach, -based approach, what can we do?what can we do?
![Page 5: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/5.jpg)
Knowledge we needKnowledge we need Nearly every drug approved on the market, by a regulatory
agency, has a known molecular mode of action. If you distinguish the molecular characteristics of a disease
from a “normal” cell’s characteristics, you can then match drugs with that disease and known molecular signaling pathways within a disease!
This is the idea fueling (i) “Combination Therapies” and (ii) “Drug Repositioning”
![Page 6: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/6.jpg)
CurrentCurrent Treatment (Rx) and Drug Treatment (Rx) and Drug Development Protocols for Development Protocols for
DiseasesDiseases Past: Age of Past: Age of One Drug WondersOne Drug Wonders
Penicillin – bacteriaPenicillin – bacteria
Now we face tougher problems… Now we face tougher problems… 1.1. Multigenetic diseasesMultigenetic diseases – cancer, Alzheimer’s and – cancer, Alzheimer’s and
Parkinson’s diseases, cardiovascular disease, Parkinson’s diseases, cardiovascular disease, MS, HIV / viruses…MS, HIV / viruses…
2.2. Disease ResistanceDisease Resistance Infectious DiseasesInfectious Diseases HIVHIV CancerCancer
![Page 7: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/7.jpg)
Disease Complexity / Disease Complexity / MultigeneityMultigeneity
Cancer has been called hundreds of sub-diseases; reason is Cancer has been called hundreds of sub-diseases; reason is because it results from multiple diff’t molecular because it results from multiple diff’t molecular dysfunctions.dysfunctions.
Molecular Signaling within cells is highly complex.Molecular Signaling within cells is highly complex.
![Page 8: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/8.jpg)
Disease ResistanceDisease Resistance
Arises fromArises from1.1. Not fully killing the diseased cells and/orNot fully killing the diseased cells and/or
2.2. Some degree of adaptive “randomness” in the Some degree of adaptive “randomness” in the disease; anddisease; and
3.3. ““Selection” to grow those diseased cells who Selection” to grow those diseased cells who were not killed or are more adept.were not killed or are more adept.
With Cancer and HIV: the molecular systems driving these diseases are constantly changing due to high mutation and growth rates. (they adapt!)
![Page 9: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/9.jpg)
Resistance Development Resistance Development withinwithin
One CellOne Cell
““Window of Opportunity” with diseases where you can Window of Opportunity” with diseases where you can strike based on armaments available, and strike HARD!strike based on armaments available, and strike HARD!
PARP up-regulated after chemotherapy, if missing DNA PARP up-regulated after chemotherapy, if missing DNA repair enzymes of BRCA and PTEN family.repair enzymes of BRCA and PTEN family.
As you see later, cocktail As you see later, cocktail couldcould be better! be better!
Cancer upregulates PARP (another DNA repairman), thus defending itself against too much DNA damage.
Cancer w.dysfunctional PTEN
Chemo
Chemo mutates DNA of cells to kill them!
Cancer w.dysfunctional PTEN
PARP-1
![Page 10: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/10.jpg)
What is a combination What is a combination therapy?therapy?
The combination of two or more separate The combination of two or more separate components – be it drugs, medical devices, or components – be it drugs, medical devices, or biological products (a substance derived from a biological products (a substance derived from a living organism), for the purpose of some end-living organism), for the purpose of some end-goal.goal.
GoalGoal
a)a) Big attack – not in size but strengthBig attack – not in size but strength
b)b) Localized attackLocalized attack
![Page 11: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/11.jpg)
ConceptConcept It’s better to fight something with two or more It’s better to fight something with two or more
small attacks specific (molecularly) to a target, small attacks specific (molecularly) to a target, both in effectiveness both in effectiveness andand safety, when compared safety, when compared to one single massive attack.to one single massive attack.
i.e., Nuke v.i.e., Nuke v. Targeted Targeted AssassinationsAssassinations
Support from Studies (all entering or in clinical Support from Studies (all entering or in clinical validation testing now):validation testing now):
1.1. Cocktail against brain tumorsCocktail against brain tumors2.2. MET / EGFR cocktail – more on this laterMET / EGFR cocktail – more on this later3.3. Chemo targeted to liver, avoiding adverse effects to heartChemo targeted to liver, avoiding adverse effects to heart4.4. HIV Cocktail – Atripla (*approved)HIV Cocktail – Atripla (*approved)5.5. Cocktail against Alzheimer’s Disease Cocktail against Alzheimer’s Disease
![Page 12: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/12.jpg)
The BenefitsThe Benefits
1.1. Greater effectiveness on disease targetGreater effectiveness on disease target
2.2. Lower side effects on host (me and you)Lower side effects on host (me and you)
3.3. Lower chance of resistance development (from Lower chance of resistance development (from disease)disease)
![Page 13: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/13.jpg)
TheoreticalTheoretical Examples: Examples:applying the conceptapplying the concept
CancerCancer
Other studies where relevance is shownOther studies where relevance is shown MSMS ALSALS Alzheimer’sAlzheimer’s Parkinson’sParkinson’s
HIVHIV Infectious diseases Infectious diseases
(viruses/bacteria)(viruses/bacteria) Hepatitis B recurrent in post Hepatitis B recurrent in post
liver transplant & Hepatitis Cliver transplant & Hepatitis C
![Page 14: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/14.jpg)
CancerCancer
EGFREGFR & & METMET therapy (on its way to clinical studies now) therapy (on its way to clinical studies now) FUS1FUS1, , MDM2MDM2, & , & P53P53 therapy (tested separately in clinical therapy (tested separately in clinical
trial)trial) PARP + Chemo – breast and ovarian cancer (in clinical PARP + Chemo – breast and ovarian cancer (in clinical
trail now)trail now) Brain Tumors – 3 proteins targeted (on its way to clinical Brain Tumors – 3 proteins targeted (on its way to clinical
studies)studies)
![Page 15: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/15.jpg)
EGFR & METEGFR & MET
““Our findings provide a strong rationale for combination Our findings provide a strong rationale for combination treatment strategies as initial therapies for some patients.” - Pasi treatment strategies as initial therapies for some patients.” - Pasi Jänne Jänne MD, PhD, of Dana-Faber Cancer Institute and Associate Professor MD, PhD, of Dana-Faber Cancer Institute and Associate Professor of Medicine at Harvard Medical Schoolof Medicine at Harvard Medical School
Status: expected to move into clinical study soonStatus: expected to move into clinical study soon
Source: http://www.medicalnewstoday.com/articles/176486.php?nfid=79262
EGFRi
Tarceva / Iressa
HGF
cancer
cancer
cancer GAB1++
cancer
cancer
cancer
cancer
cancer
MET
EGFR
METi
Tumor Response
![Page 16: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/16.jpg)
FUS1FUS1, , MDM2MDM2, & , & P53P53 therapytherapy
Tested in clinical trials separately.
![Page 17: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/17.jpg)
PARP inhibitors & PARP inhibitors & ChemoChemo
Being tested in clinical trial now, with “very Being tested in clinical trial now, with “very promising results.” – Medscape articlepromising results.” – Medscape article
PTEN + BRCA 1/2 + PARP = DNA Repairmen
When no PTEN (or BRCA1/2), PARP is active/over-expressed, especially in cancers after undergoing chemotherapy.
Idea for Cancer Therapy is giving PARP inhibitors to people who have already undergone chemotherapy to prevent this defense mechanism OR PARP inhibitors, with chemo, as a first line treatment.
This makes sense b/c cancer cells don’t want to be mutated and die from the chemotherapy, thus defend themselves through upregulating PARPs (repairmen) when they don’t have PTEN or BRCA proteins.
Sources: http://www.medscape.com/viewarticle/704990; http://news.bbc.co.uk/2/hi/health/8256494.stm; http://breastcancer.about.com/od/targetedbiologictherapies/p/parp_basics.htm
![Page 18: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/18.jpg)
Brain tumorsBrain tumors
1.1. Interleukin 13 receptor alpha 2 (IL-13R-alpha),Interleukin 13 receptor alpha 2 (IL-13R-alpha),2.2. Ephrin receptor A2 (EphA2)Ephrin receptor A2 (EphA2)3.3. Fos-related antigen 1 (Fra-1)Fos-related antigen 1 (Fra-1)Among 76 patients with brain tumors, all with Among 76 patients with brain tumors, all with
GBMs had one marker present and 95% had at GBMs had one marker present and 95% had at least two of these markers.least two of these markers.
““The three markers were not found in healthy brain The three markers were not found in healthy brain tissue, suggesting that the proteins are highly tissue, suggesting that the proteins are highly suited as targets for therapies designed to kill suited as targets for therapies designed to kill cancer cells and spare healthy brain tissue.”cancer cells and spare healthy brain tissue.”
Source: http://www.drugresearcher.com/Emerging-targets/A-drug-cocktail-to-bust-brain-tumours
![Page 19: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/19.jpg)
A few quotesA few quotes ““This is why it's so important to be able to use a combination of This is why it's so important to be able to use a combination of
more than one drug. If the virus mutates tomore than one drug. If the virus mutates to become resistant to become resistant to one drug, it is still sensitive to the other drugsone drug, it is still sensitive to the other drugs.”.”
-- Genhong Cheng, Genhong Cheng, Research team member at the UCLA Center for Cell Research team member at the UCLA Center for Cell Control and UCLA's Jonsson Comprehensive Cancer CenterControl and UCLA's Jonsson Comprehensive Cancer Center
““Drug combinations can also be used effectively to inhibit Drug combinations can also be used effectively to inhibit infectious diseases because resistance to a single drug is very infectious diseases because resistance to a single drug is very common… If we can apply multiple drugs against one infectious common… If we can apply multiple drugs against one infectious agent, it probably will prevent the occurrence of drug agent, it probably will prevent the occurrence of drug resistance.”resistance.”
- Ren Sun, Ren Sun, UCLA Professor of Molecular and Medical Pharmacology and UCLA Professor of Molecular and Medical Pharmacology and research team memberresearch team member
From a study finding that total inhibition of a virus occurred at From a study finding that total inhibition of a virus occurred at much lower drug doses than would be necessary if the drugs much lower drug doses than would be necessary if the drugs were used alone (~10% less than required when each drug is were used alone (~10% less than required when each drug is adminstered individually)adminstered individually)
![Page 20: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/20.jpg)
But, rememberBut, remember
AlwaysAlways ask: Why, How, What, and ask: Why, How, What, and WHENWHEN
Any Questions?Any Questions?
![Page 21: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/21.jpg)
Ex of Cocktails ApprovedEx of Cocktails Approved
Only one approved cocktail comes to Only one approved cocktail comes to mind –mind –
1.1. HIV, there is now one “cocktail” pill you HIV, there is now one “cocktail” pill you can take which includes all three primary can take which includes all three primary therapies for the disease.therapies for the disease.
Approved post approval of each individual Approved post approval of each individual component.component.
2.2. Combo, chemotherapies + monoclonal Combo, chemotherapies + monoclonal Antibodies like Herceptin / EGFR targetsAntibodies like Herceptin / EGFR targets
Approved after testing one experimental therapy Approved after testing one experimental therapy in combo with already approved chemo drugs.in combo with already approved chemo drugs.
![Page 22: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/22.jpg)
WhenWhen
WhenWhen matters! matters!
If you don’t get why after these next few If you don’t get why after these next few slides, stop me in my tracks!!slides, stop me in my tracks!!
![Page 23: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/23.jpg)
Importance of Timing in the Importance of Timing in the Development of Combo-Development of Combo-
TherapiesTherapiesPhysician Developed
1.1. Two or more approved therapiesTwo or more approved therapies Dosage and interactions are untested!Dosage and interactions are untested! Possibly can try to predict dosage/interactionsPossibly can try to predict dosage/interactions
Pharma Development by testingPharma Development by testing
2.2. An approved therapy with (i) an investigational or (ii) An approved therapy with (i) an investigational or (ii) another approved therapyanother approved therapy
Avg time for development – Avg time for development – 14 years14 years for a cancer for a cancer therapy!therapy!
Many pharmas know now of possible combo benefits, but test each drug one at a time anyway..
3.3. Combo of two investigational therapiesCombo of two investigational therapies Never happened to my knowledgeNever happened to my knowledge
![Page 24: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/24.jpg)
Problems with Physician Problems with Physician Developed CombinationsDeveloped Combinations
Each individual component is tested for max Each individual component is tested for max tolerable dose…tolerable dose… Hence, when combining two or more drugs, Hence, when combining two or more drugs,
physicians have no idea what dose to give physicians have no idea what dose to give patientspatients
Also: potential interactions between drugs are Also: potential interactions between drugs are unknown.unknown.
![Page 25: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/25.jpg)
Innovation in the WorksInnovation in the Works The development of cocktails The development of cocktails from pharmasfrom pharmas
(where dosage and safety are tested prior to (where dosage and safety are tested prior to administration to patients)administration to patients)
Drug repositioningDrug repositioning
But, for nowBut, for now
![Page 26: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/26.jpg)
Combination Rxs Used NowCombination Rxs Used Now
Combination therapies are primarily created by Combination therapies are primarily created by physicians through “off-label use” or already physicians through “off-label use” or already approved chemotherapy-combo regimens.approved chemotherapy-combo regimens.
![Page 27: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/27.jpg)
What to do?What to do?
Ask your physician about being Ask your physician about being treated with a potent, specific treated with a potent, specific regimen–targeted to regimen–targeted to youryour disease– disease–especially, if you are dealing with a especially, if you are dealing with a seriously compromising illness.seriously compromising illness.
Ask your doc Qs:Ask your doc Qs: “How, what, why, “How, what, why, and when?”and when?”
![Page 28: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/28.jpg)
What is I&C Doing?What is I&C Doing?
Bringing innovation to you at the Bringing innovation to you at the fastest rate possiblefastest rate possible is our goal. is our goal.
1.1. Community-based education and resource Community-based education and resource sharingsharing
2.2. Building an interface to empower you to make Building an interface to empower you to make a difference a difference
3.3. Working to integrate these innovations and Working to integrate these innovations and patient options into physicians’ workflow.patient options into physicians’ workflow.
![Page 29: Combination Therapies](https://reader035.fdocuments.net/reader035/viewer/2022081421/557974ffd8b42a3a5c8b5460/html5/thumbnails/29.jpg)
Combination Therapy Combination Therapy ResourcesResources
Targeted Drug Delivery ToolTargeted Drug Delivery Tool IsoFlowIsoFlow Ultrasound released therapy (untested in Ultrasound released therapy (untested in
humans)humans) UV activated therapy (untested in humans)UV activated therapy (untested in humans)
Drug repositioning / finding for your diseaseDrug repositioning / finding for your disease GeneGoGeneGo – – MetacoreMetacore BiovistaBiovista
Targeted approach specifically for cancer– Targeted approach specifically for cancer– N-of-OneN-of-One Intervention InsightsIntervention Insights / / GeneGoGeneGo ICANICAN